Skip to main content
. Author manuscript; available in PMC: 2017 Oct 23.
Published in final edited form as: Mol Psychiatry. 2015 Feb 10;20(12):1516–1524. doi: 10.1038/mp.2014.191

Figure 2.

Figure 2

Relationships between lifetime cumulative dose of methamphetamine (MA) and standardized Z-scores for mean thickness of gray matter regions of interest (ROIs) in adolescent MA users. Scatter plots and regression lines indicate the relationships between lifetime cumulative dose of MA and standardized Z-scores for thickness of gray matter ROIs (OFC, r =− 0.32, P =0.07; precuneus, r =− 0.41, P =0.009; inferior parietal cortex (IPC), r =− 0.36, P =0.03) in adolescent MA users. *P<0.05; **P<0.01.